AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12831221 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 18
Study 11784351 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 22
Study 11784351 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 9369038 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL‐apheresis plus simvastatin
Number of subjects: 0
Study 9369038 — intervention group
Group type: COMPARATOR
Intervention: Conventional drug treatment alone
Number of subjects: 0
Study 8249557 — intervention group
Group type: EXPERIMENTAL
Intervention: isoflurane
Number of subjects: 12
Study 8249557 — intervention group
Group type: EXPERIMENTAL
Intervention: halothane
Number of subjects: 12
Study 3514233 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride (slow i.v. injection)
Number of subjects: 9
Study 3514233 — intervention group
Group type: COMPARATOR
Intervention: Placebo (slow i.v. injection)
Number of subjects: 9
Study 29309089 — intervention group
Group type: EXPERIMENTAL
Intervention: One-on-one in-person consultation to discuss CRC screening and the screening process, as well as a FIT.
Number of subjects: 3415
Study 29309089 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone call to discuss CRC screening and the screening process before receiving a FIT in the mail.
Number of subjects: 3415
Study 29309089 — intervention group
Group type: COMPARATOR
Intervention: Control group: Patients who were mailed a FIT with a letter explaining the importance of completing the FIT and instructions.
Number of subjects: 3415
Study 26780376 — intervention group
Group type: EXPERIMENTAL
Intervention: BR decision support aid
Number of subjects: 55
Study 26780376 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 55
Study 24852301 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led psychoeducational intervention plus usual care
Number of subjects: 300
Study 24852301 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 300
Study 22494043 — intervention group
Group type: EXPERIMENTAL
Intervention: New irrigation design catheter (group A, 40 patients)
Number of subjects: 80
Study 22494043 — intervention group
Group type: COMPARATOR
Intervention: Standard irrigated catheter (group B, 40 patients)
Number of subjects: 80
Study 22494043 — intervention group
Group type: EXPERIMENTAL
Intervention: New irrigation design catheter (group A)
Number of subjects: 80
Study 22494043 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraprocedural ACT
Number of subjects: 80
Study 20417153 — intervention group
Group type: EXPERIMENTAL
Intervention: S1-root stimulation
Number of subjects: 55
Study 20417153 — intervention group
Group type: COMPARATOR
Intervention: Tibial nerve stimulation
Number of subjects: 55
Study 20417153 — intervention group
Group type: COMPARATOR
Intervention: L4/L5-level stimulation
Number of subjects: 55
Study 18581440 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 270
Study 15836533 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive patient education (one-on-one session by primary care nurses, 2-page handout on CRC screening)
Number of subjects: 788
Study 15836533 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive patient education
Number of subjects: 788
Study 15836533 — intervention group
Group type: COMPARATOR
Intervention: Standard patient education (FOBT cards and written instructions from manufacturer)
Number of subjects: 788
Study 15836533 — intervention group
Group type: COMPARATOR
Intervention: Standard patient education
Number of subjects: 788
Study 11480744 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based care
Number of subjects: 0
Study 11480744 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized trials
Number of subjects: 0
Study 11480744 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational, descriptive, and qualitative methods
Number of subjects: 0
Study 9778331 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrioverter
Number of subjects: 51
Study 8164028 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolasetron mesylate (1.8, 2.4, 3.0, and 5.0 mg/kg) administered intravenously over 20 minutes, starting 30 minutes before chemotherapy.
Number of subjects: 89
Study 8164028 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolasetron mesylate (doses > 2.4 mg/kg)
Number of subjects: 89
Study 3415894 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated training programme
Number of subjects: 32
Study 3415894 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching method
Number of subjects: 32
Study 1920009 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release delivery of chlorhexidine (SRD)
Number of subjects: 10
Study 1920009 — intervention group
Group type: COMPARATOR
Intervention: Routine maintenance therapy (RMT)
Number of subjects: 10
Study 582685 — intervention group
Group type: EXPERIMENTAL
Intervention: L-tryptophane plus oxprenolol
Number of subjects: 38
Study 582685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 31519283 — intervention group
Group type: EXPERIMENTAL
Intervention: Quercetin 500 mg/day for 12 weeks
Number of subjects: 84
Study 31519283 — intervention group
Group type: COMPARATOR
Intervention: Starch placebo 500 mg/day for 12 weeks
Number of subjects: 84
Study 28095099 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-nutritional supplement program (ENP)
Number of subjects: 121
Study 28095099 — intervention group
Group type: COMPARATOR
Intervention: Health education program (SAP)
Number of subjects: 121
Study 25555385 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced Nicotine Content Cigarettes (RNC)
Number of subjects: 51
Study 23816271 — intervention group
Group type: EXPERIMENTAL
Intervention: pegylated interferon α 2b
Number of subjects: 57
Study 23816271 — intervention group
Group type: EXPERIMENTAL
Intervention: pegylated interferon α 2a
Number of subjects: 57
Study 23816271 — intervention group
Group type: COMPARATOR
Intervention: pegylated interferon α 2b and α 2a
Number of subjects: 57
Study 21238470 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating at a fast rate (FM) - 7 minutes
Number of subjects: 25
Study 21238470 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating at a medium rate (MM) - 14 minutes
Number of subjects: 25
Study 21238470 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating at a slow rate (SM) - 28 minutes
Number of subjects: 25
Study 21238470 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum energy intake at the next meal
Number of subjects: 25
Study 19127178 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) group
Number of subjects: 18
Study 19127178 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental (EXP) group
Number of subjects: 18
Study 17917321 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg plus Hydrochlorothiazide 12.5 mg
Number of subjects: 0
Study 17917321 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg plus Hydrochlorothiazide 6.25 mg
Number of subjects: 0
Study 17917321 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 25 mg plus Hydrochlorothiazide 6.25 mg
Number of subjects: 0
Study 17917321 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 12.5 mg
Number of subjects: 0
Study 17917321 — intervention group
Group type: COMPARATOR
Intervention: Losartan 50 mg
Number of subjects: 0
Study 17917321 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15536109 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (6.25-25 mg, twice daily)
Number of subjects: 1235
Study 15536109 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol tartrate (50-200 mg, twice daily)
Number of subjects: 1235
Study 15536109 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 1235
Study 15536109 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 1235
Study 11870676 — intervention group
Group type: COMPARATOR
Intervention: Flunisolide CFC 1000 microg bid
Number of subjects: 31
Study 11870676 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide HFA 170 microg bid
Number of subjects: 31
Study 11870676 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide HFA 340 microg bid
Number of subjects: 31
Study 11870676 — intervention group
Group type: COMPARATOR
Intervention: Flunisolide CFC
Number of subjects: 31
Study 11870676 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide HFA
Number of subjects: 31
Study 9121940 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% low-fat diet
Number of subjects: 194
Study 9121940 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention usual diet
Number of subjects: 194
Study 7942779 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum vitamin B12 levels in asymptomatic HIV seropositive patients
Number of subjects: 218
Study 7942779 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsaturated B12 binding capacities of transcobalamins I and II in asymptomatic HIV seropositive patients
Number of subjects: 218
Study 7942779 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical progression to ARC or AIDS in asymptomatic HIV seropositive patients
Number of subjects: 218
Study 7942779 — intervention group
Group type: EXPERIMENTAL
Intervention: CD4 counts in asymptomatic HIV seropositive patients
Number of subjects: 218
Study 7942779 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum B12 levels over 2 1/2 years in asymptomatic HIV seropositive patients
Number of subjects: 218
Study 3330987 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate-release (IR) verapamil
Number of subjects: 58
Study 3330987 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) verapamil
Number of subjects: 58
Study 31702397 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-rehabilitation
Number of subjects: 77
Study 31702397 — intervention group
Group type: COMPARATOR
Intervention: Hospital-based cardiac rehabilitation
Number of subjects: 77
Study 30974306 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-Based Rehabilitation (CBR) intervention using psychoeducation and social skill modules for 12 weeks.
Number of subjects: 100
Study 30974306 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 100
Study 30974306 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-Based Rehabilitation (CBR) intervention.
Number of subjects: 100
Study 28368183 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused Academic Strength Training (FAST)
Number of subjects: 72
Study 28368183 — intervention group
Group type: COMPARATOR
Intervention: Services as usual
Number of subjects: 72
Study 26087214 — intervention group
Group type: EXPERIMENTAL
Intervention: TVT-O procedure
Number of subjects: 100
Study 26087214 — intervention group
Group type: EXPERIMENTAL
Intervention: AJUST procedure
Number of subjects: 100
Study 23909568 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical removal of plaque every 12 hours
Number of subjects: 52
Study 23909568 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical removal of plaque every 24 hours
Number of subjects: 52
Study 23909568 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical removal of plaque every 48 hours
Number of subjects: 52
Study 23909568 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical removal of plaque every 72 hours
Number of subjects: 52
Study 23909568 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical removal of plaque every 48 and 72 hours
Number of subjects: 52
Study 21166828 — intervention group
Group type: EXPERIMENTAL
Intervention: Emdogain Gel (Biora AB, Malmö, Sweden)
Number of subjects: 18
Study 21166828 — intervention group
Group type: COMPARATOR
Intervention: Calcium hydroxide
Number of subjects: 18
Study 18436034 — intervention group
Group type: EXPERIMENTAL
Intervention: Cone-beam tomography (CBT)
Number of subjects: 74
Study 18436034 — intervention group
Group type: COMPARATOR
Intervention: Periapical radiography (PA)
Number of subjects: 74
Study 16525002 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-session social skills intervention
Number of subjects: 92
Study 16525002 — intervention group
Group type: COMPARATOR
Intervention: Two-hour standard HIV educational session
Number of subjects: 92
Study 15095765 — intervention group
Group type: EXPERIMENTAL
Intervention: Cochrane Controlled Trials Register
Number of subjects: 0
Study 15095765 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDLINE
Number of subjects: 0
Study 15095765 — intervention group
Group type: EXPERIMENTAL
Intervention: Embase
Number of subjects: 0
Study 15095765 — intervention group
Group type: EXPERIMENTAL
Intervention: Science/Social Sciences Citation Index
Number of subjects: 0
Study 15095765 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional databases searched after CCTR, MEDLINE, and Embase
Number of subjects: 0
Study 15095765 — intervention group
Group type: COMPARATOR
Intervention: CCTR, MEDLINE, and Embase
Number of subjects: 0
Study 11344463 — intervention group
Group type: EXPERIMENTAL
Intervention: Random tickets
Number of subjects: 60
Study 11344463 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived randomness
Number of subjects: 60
Study 9469526 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis (HYP)
Number of subjects: 60
Study 9469526 — intervention group
Group type: COMPARATOR
Intervention: Stress reducing strategies (CONT)
Number of subjects: 60
Study 7934491 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg cA2
Number of subjects: 73
Study 7934491 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/kg cA2
Number of subjects: 73
Study 7934491 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 2904392 — intervention group
Group type: EXPERIMENTAL
Intervention: sulphasalazine 2 g/day
Number of subjects: 23
Study 2904392 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 23
Study 31143466 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological First Aid (PFA) training
Number of subjects: 72
Study 31143466 — intervention group
Group type: EXPERIMENTAL
Intervention: Short training programmes for PFA
Number of subjects: 72
Study 27673360 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH, 32‐34°C)
Number of subjects: 148
Study 27673360 — intervention group
Group type: COMPARATOR
Intervention: Fever control (35.5‐37.0°C)
Number of subjects: 148
Study 27673360 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients (combined analysis)
Number of subjects: 148
Study 25263400 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-stage surgical technique
Number of subjects: 67
Study 25263400 — intervention group
Group type: COMPARATOR
Intervention: 1-stage surgical technique
Number of subjects: 67
Study 25263400 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone grafting
Number of subjects: 67
Study 23886756 — intervention group
Group type: EXPERIMENTAL
Intervention: Routines-based early intervention (RBEI)
Number of subjects: 31
Study 23886756 — intervention group
Group type: COMPARATOR
Intervention: Traditional home visiting (THV)
Number of subjects: 31
Study 21729166 — intervention group
Group type: EXPERIMENTAL
Intervention: 311 nm UVB therapy
Number of subjects: 4
Study 21729166 — intervention group
Group type: COMPARATOR
Intervention: Non-irradiated body halves
Number of subjects: 4
Study 19479151 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic fields
Number of subjects: 483
Study 19479151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 483
Study 16916540 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling intervention
Number of subjects: 163
Study 16916540 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 163
Study 15321432 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine
Number of subjects: 565
Study 15321432 — intervention group
Group type: COMPARATOR
Intervention: 0.2% ropivacaine
Number of subjects: 565
Study 10903487 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 200 microg once daily
Number of subjects: 904
Study 10903487 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate 100 microg twice daily
Number of subjects: 904
Study 10903487 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 500 microg once daily
Number of subjects: 904
Study 10903487 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate 250 microg twice daily
Number of subjects: 904
Study 10903487 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (both regimens)
Number of subjects: 904
Study 9018514 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical upper airway anesthesia with 0.2% tetracaine
Number of subjects: 7
Study 9018514 — intervention group
Group type: COMPARATOR
Intervention: Sham anesthesia (Control)
Number of subjects: 7
Study 1549927 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 min preoxygenation
Number of subjects: 11
Study 1549927 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 min preoxygenation
Number of subjects: 11
Study 4073600 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate aerosol canister with new longer, snout-like nozzle adapters
Number of subjects: 48
Study 4073600 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate aerosol canister with currently available delivery system
Number of subjects: 48
Study 31886216 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training intervention group (N=70)
Number of subjects: 140
Study 31886216 — intervention group
Group type: COMPARATOR
Intervention: Control group (N=70)
Number of subjects: 140
Study 31886216 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training intervention
Number of subjects: 140
Study 29864430 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glucosamine hydrochloride (1.44 g/day) combined with hyaluronate sodium injections
Number of subjects: 144
Study 29864430 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo combined with hyaluronate sodium injections
Number of subjects: 144
Study 27798329 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-grain diet
Number of subjects: 40
Study 27798329 — intervention group
Group type: COMPARATOR
Intervention: Refined-grain diet (Control)
Number of subjects: 40
Study 23763270 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical nicotinamide (NCT) 4% cream
Number of subjects: 48
Study 23763270 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle without NCT)
Number of subjects: 48
Study 22387875 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week strengthening and stretching intervention program (3 times per week)
Number of subjects: 44
Study 19828470 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab (750 mg, n = 5)
Number of subjects: 11
Study 19828470 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab (1500 mg, n = 5)
Number of subjects: 11
Study 19828470 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 11
Study 19828470 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 6)
Number of subjects: 11
Study 19828470 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 17286233 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated CRP levels
Number of subjects: 141
Study 17286233 — intervention group
Group type: COMPARATOR
Intervention: IL-6G(-174)C genotype
Number of subjects: 141
Study 17286233 — intervention group
Group type: COMPARATOR
Intervention: IL1RA genotype
Number of subjects: 141
Study 17286233 — intervention group
Group type: COMPARATOR
Intervention: CRP levels
Number of subjects: 141
Study 16128937 — intervention group
Group type: EXPERIMENTAL
Intervention: IL1RN*2 allele carriers
Number of subjects: 731
Study 16128937 — intervention group
Group type: EXPERIMENTAL
Intervention: Two‐variant allele carriers who were also homozygous for the IL1B‐31*T allele
Number of subjects: 731
Study 16128937 — intervention group
Group type: EXPERIMENTAL
Intervention: Haplotype IL1RN*2/IL1B‐31*T
Number of subjects: 731
Study 12143913 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine controlled-release (CR) 25-62.5 mg/day
Number of subjects: 640
Study 12143913 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine immediate-release (IR) 20-50 mg/day
Number of subjects: 640
Study 12143913 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 640
Study 12143913 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine CR
Number of subjects: 640
Study 12143913 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine IR
Number of subjects: 640
Study 9929085 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity program
Number of subjects: 235
Study 9929085 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured exercise program
Number of subjects: 235
Study 9868616 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver-coated medical devices
Number of subjects: 0
Study 9868616 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver preparations in burns
Number of subjects: 0
Study 1832454 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg naproxen b.i.d. for 3 months
Number of subjects: 15
Study 1832454 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 6623556 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutron irradiation
Number of subjects: 115
Study 6623556 — intervention group
Group type: COMPARATOR
Intervention: Photon irradiation
Number of subjects: 115
Study 30716790 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Calsurf administration (n=154)
Number of subjects: 305
Study 30716790 — intervention group
Group type: COMPARATOR
Intervention: Rescue Calsurf administration (n=151)
Number of subjects: 305
Study 29396276 — intervention group
Group type: EXPERIMENTAL
Intervention: High alcohol levels (0.6gL-1)
Number of subjects: 18
Study 29396276 — intervention group
Group type: COMPARATOR
Intervention: Postcall surgeons
Number of subjects: 18
Study 27679519 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with losartan and lisinopril
Number of subjects: 1148
Study 27679519 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy with losartan
Number of subjects: 1148
Study 24910383 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid garlic extract (LGE)
Number of subjects: 50
Study 24910383 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 50